Cancer Biology & Therapeutics
April 23 - 27, 2013
Abstract Deadline: February 25, 2013

Organizers:
Senthil Muthuswamy, Ontario Cancer Institute, Canada
Kornelia Polyak, Dana Farber Cancer Institute
David Tuveson, Cold Spring Harbor Laboratory

You are cordially invited to participate in the second meeting on Cancer Biology & Therapeutics to be held at Cold Spring Harbor Laboratory, New York. The meeting will begin on Tuesday, April 23, 2013, and will conclude with lunch on Saturday, April 27. The specific goal of this conference is to bring together a diverse group of scientists studying various aspects of the biology of cancer. The meeting will alternate annually with the CSHL meeting on Mechanisms & Models of Cancer.

The format of the meeting will include morning and evening sessions consisting of eight or nine 15-minute talks per session, selected from the abstracts, principally on unpublished work. In addition, there will be two poster sessions, held in the afternoons. The organizers will decide the suitability of each abstract for oral or poster presentation, but please specify if you prefer a poster.  

Keynote Speakers:
William Kaelin, HHMI/Dana-Farber Cancer Institute

Topics & Speakers Include:
Tumor cell plasticity and microenvironment
Ben Stanger, University of Pennsylvania
Valerie Weaver, University of California, San Francisco

Tumor heterogeneity -I: Genetic
Elaine Mardis, Washington University School of Medicine
Mike Wigler, Cold Spring Harbor Laboratory

Tumor heterogeneity- II: Epigenetic
Myles Brown, Dana Farber Cancer Institute

Signaling networks and therapeutics
Neal Rosen, Memorial Sloan-Kettering Cancer Center
Lewis Cantley, Weill Cornell Cancer Center

Immunotherapy
James Allison, UT MD Anderson Cancer Center
Bob Vonderheide, University of Pennsylvania

Metabolism
Joan Brugge, Harvard Medical School
Ronald Evans, The Salk Institute

Diagnostic imaging and drug delivery
Rakesh Jain, Massachusetts General Hospital
Kevin Brindle, University of Cambridge, UK

Translational trial/Personalized cancer therapy
Lillian Siu, Princess Margaret Hospital, Canada
Larry Norton, Memorial Sloan-Kettering Cancer Center

Panel Sessions:
Preclinical Models & Clinical Trial Design
Whole Genome Sequencing & Personalized Cancer
Medicine

Abstracts should contain only new and unpublished material and must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers and individual session chairs. Status (talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.

We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. We have applied for funds from government and industry to partially support graduate students and postdocs. Apply in writing to Val Pakaluk (pakaluk@cshl.edu) stating need for financial support - preference is given to those submitting abstracts.

We look forward to seeing you at Cold Spring Harbor in April.

Major support for this conference is provided by:
Astellas Pharma Inc.
Additional support for this conference may be provided by:
National Cancer Institute

We have funds to provide partial scholarships for individuals who are US citizens/permanent residents from minority groups under-represented in the life sciences. Please provide justification in writing to Val Pakaluk (pakaluk@cshl.edu)and state your financial needs. Preference will be given to those applying who submit abstracts to the meeting.

---

Regular packages are all inclusive and cover registration, food, housing, parking, wine-and-cheese party, lobster banquet, etc. No Housing packages include all costs except housing. Full payment is due 4 weeks prior to the meeting.